Worldwide Obesity and Weight Loss Treatment to Reach $9 Billion By 2010
Posted on: Thursday, 7 September 2006, 12:00 CDT
NEW YORK, Sept. 7 /PRNewswire/ -- With surgical interventions already skyrocketing as a means to fight obesity, the overall global obesity treatment market is expected to rapidly advance to upwards of $9 billion by 2010.
In 2005 alone, surgical interventions accounted for 68.9% of revenues, according to Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment, a new study from Kalorama Information. As the rates of worldwide obesity continue to climb over the next four years, surgical interventions are expected to increase substantially, accounting for 82.5% of the market.
Prescription and over-the-counter anti-obesity and weight loss pharmaceuticals -- two categories which complete the obesity management market -- pale in comparison in market share and revenues, primarily due to competitive pressures from the surgical segment. These pharmaceutical segments also struggle with fallout from the failure of breakthrough anti-obesity drugs and the inability of current drugs to produce major weight loss for the majority of patients.
"A major reason for the difficulty in developing anti-obesity drugs, and the minimal efficacy of those that have been developed, is that the condition is exceptionally complex, involving many poorly understood pathways," acknowledges Mary Anne Crandall, the report's author. "In this report we not only look at the rising incidence of global obesity, but at the sociological, environmental, genetic, and biological factors that are being studied as indicators for the disease. We also consider the healthcare and economic implications that the worldwide obesity epidemic is bringing about, as the costs to society are increasing at a rapid rate as well."
Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment details the various categories of the obesity and weight loss markets; describes the worldwide market for prescription and over-the-counter anti- obesity and weight loss pharmaceuticals and surgical interventions; and identifies major market factors that may help to shape the worldwide market for obesity and weight loss management in the future. The report's comprehensive introduction also provides a thorough analysis of the nature of obesity as a disease. It can be purchased directly from Kalorama Information by clicking http://www.kaloramainformation.com/pub/1190852.html. It is also available at MarketResearch.com.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit http://www.kaloramainformation.com/.
Kalorama Information
CONTACT: Tom Ehart, MarketResearch.com, +1-240-747-3014,tehart@marketresearch.com, for Kalorama Information
Web site: http://www.marketresearch.com/http://www.kaloramainformation.com/http://www.kaloramainformation.com/pub/1190852.html
Source: PRNewswire
Related Articles
- Obesity Drugs Help 'Modest' Weight Loss
- Experts Question New OTC Weight-Loss Drug
- Liberty Diversified Holdings, Inc. Announces Acquisition of New Subsidiary and Worldwide Marketing Rights to Serotrim Patented Weight Loss Drink and 'The Serotrim(R) Power Diet'
- Attendance at Weight Watchers(R) Meetings Strongly Linked to Weight-Loss and Health Improvements
- Weight Loss Reduces Frailty in Obese Older Adults
- eFoodSafety.Com, Inc. To Distribute 24-Hour Weight Loss Formula; Trimmendous(TM) to Draw On $33+ Billion Domestic Market of Obesity
- Weight loss pep talks by phone can work
- New Study Demonstrates Greater Fitness Benefits of Comprehensive Weight Loss Program Over Just Exercise Alone
- Racial and Socioeconomic Differences in the Weight-Loss Experiences of Obese Women
- World's Fastest Growing Weight Loss Company Weighs in on New Food Pyramid
User Comments (0)
RSS Feeds